{
  "id": 18132099,
  "title": "Spyre’s arthritis misses; Ideaya ends eye cancer trial",
  "url": "https://urgent.news/2026/11/04/spyres-arthritis-misses-ideaya-ends-eye-cancer-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-04T14:39:42.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/spyres-arthritis-misses-ideaya-ends-eye-cancer-trial/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about United Therapeutics. Spyre Therapeutics reports additional trial failures: The biotech said its long-acting anti-TL1A drug, codenamed SPY072, did not meet the primary endpoints in the psoriatic arthritis or ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}